Showing results (6411-6420 of 27,720) with videos related to
Sort By:
Pageof 2,772
Vaccine|January 6, 2024
Exploring preventive care practices among unvaccinated individuals in the United States during the COVID-19 pandemicDejan K Filipas, Muhieddien Labban, Edoardo Beatrici, et al.Vaccine|January 6, 2024
Heat-inactivated mycobacteria activate the toll-like receptor 2 and 4 pathways in the zebrafish model of tuberculosisElisa Ferreras-Colino, Marinela Contreras, María A Risalde, et al.Vaccine|January 5, 2024
Racial and ethnic differences in COVID-19 vaccine readiness among adults in the United States, January 2021-April 2023Elissa C Kranzler, Timothy O Ihongbe, Michael C Marshall, et al.Vaccine|January 5, 2024
Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions - A cross-sectional study in six EU member statesCaroline Buhl, Ramune Jacobsen, Anna Birna Almarsdóttir, et al.Vaccine|December 29, 2023
Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infectionAlbert To, Teri Ann S Wong, Aquena H Ball, et al.Vaccine|December 22, 2023
The Brighton collaboration standardized module for vaccine benefit-risk assessmentBennett Levitan, Stephen C Hadler, William Hurst, et al.Vaccine|December 17, 2023
Comparing performance of year-round and campaign-mode influenza vaccination strategies among children aged 6-23 months in Kenya: 2019-2021Jeanette Dawa, Rose Jalang'o, Harriet Mirieri, et al.Vaccine|December 16, 2023
Characterization of SARS-CoV-2-specific humoral immunity and associated factors in the healthy population post-vaccinationXiao-Yong Zhan, Yun Chen, Xiaoying Zhang, et al.Vaccine|December 14, 2023
Identification of T cell and linear B cell epitopes on African horse sickness virus serotype 4 proteins VP1-1, VP2, VP4, VP7 and NS3Erika Faber, Antoinette van Schalkwyk, Selaelo Ivy Tshilwane, et al.Vaccine|December 14, 2023
Impact of the COVID-19 pandemic on routine vaccination coverage under varying prevalence Conditions: A cohort study in Beijing, ChinaZhiqiang Cao, Rui Yu, Qianli Yuan, et al.Pageof 2,772